IRCT20240224061097N1
Recruiting
Phase 3
Comparison between prophylactic antiemetic effects of Ondansetron and Haloperidol patients undergoing mastectomy- double-blind clinical trial
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Iran University of Medical Sciences
- Enrollment
- 50
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All candidate patients for bilateral mastectomy 2 side
- •ASA class 1 and 2 patients
- •All patients with general anesthesia
- •Patients aged 35\-60\.
Exclusion Criteria
- •Duration of surgery more than 150 minutes
- •Parkinson's disease
- •Patients with a history of psychiatric disorders
- •History of chemotherapy and radiation therapy
- •History of nausea and vomiting in previous surgeries
- •Having a movement disorder patient with a history of malignancy
- •Patients with prolonged QT interval
- •Use of opioids, sedatives, or any type of analgesic within one week before mastectomy History of alcohol consumption
- •History of drug abuse
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Comparison of antiemetic effectiveness and safety of palonosetron and dexamethasone with palonosetron, dexamethasone and aprepitant in patients with lung cancer receiving combination therapy with carboplatin: A phase II randomized studyJPRN-UMIN000010056Hamamatsu University School of Medicine80
Completed
Not Applicable
The effectiveness of prophylactic antiemetics 'syouhangekabukuryouto' on postoperative nausea and vomiting patientswomen who will receive laparoscopic gynecologic surgeryJPRN-UMIN000018381Saiseikai Central Hospital20
Recruiting
Not Applicable
Study of the relationship between antiemetic effect of aprepitrant and genetic polymorphism of ABC transporterJPRN-UMIN000004910Department of Clinical Pharmacology and Genitics, School of Pharmaceutical Science, Univercity of Shizuoka100
Recruiting
Not Applicable
Comparitive study of two antiemetic drugs group to decrease the chances of emesis after Laproscopic CholecyestectomyCTRI/2018/07/014830Dr RPGMC TANDA84
Completed
Phase 2
Clinical evaluation of two antiemetic combinations palonosetron dexamethazone in paclitaxel and carboplatin: a randomized phase II trial.patients with gynecological malignancies who are receiving paclitaxel/carboplatin.JPRN-UMIN000007491ara Medical University80